Time to Relapse Following Rituximab Therapy in Rheumatoid Arthritis and Its Determinants: A Single-Center Observational Study.
- DOI
- 10.7759/cureus.110939
- Published
- 2026-06-15
- Container
- Cureus
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.7759/cureus.110939,
title = {Time to Relapse Following Rituximab Therapy in Rheumatoid Arthritis and Its Determinants: A Single-Center Observational Study.},
author = {El Moubarik I and El Binoune I and Rostom S and Ghoullam G and Amine B and Zemrani S and Zeghari Z and Bahiri R.},
year = {2026},
journal = {Cureus},
doi = {10.7759/cureus.110939},
url = {https://doi.org/10.7759/cureus.110939}
}RIS
TY - JOUR TI - Time to Relapse Following Rituximab Therapy in Rheumatoid Arthritis and Its Determinants: A Single-Center Observational Study. AU - El Moubarik I AU - El Binoune I AU - Rostom S AU - Ghoullam G AU - Amine B AU - Zemrani S AU - Zeghari Z AU - Bahiri R. PY - 2026 JO - Cureus DO - 10.7759/cureus.110939 UR - https://doi.org/10.7759/cureus.110939 ER -
APA
I, E. M., I, E. B., S, R., G, G., B, A., S, Z., Z, Z., & R., B. (2026). Time to Relapse Following Rituximab Therapy in Rheumatoid Arthritis and Its Determinants: A Single-Center Observational Study.. Cureus. https://doi.org/10.7759/cureus.110939
Source records
- europe-pmc · retrieved 2026-09-26T06:33:15.859Z